Capital Southwest is a business development company that provides financing to U.S. middle-market companies. It primarily originates first-lien and other senior debt investments, sometimes with equity co-investments, to support growth, acquisitions and recapitalizations. Portfolio companies typically span industrial, services and other private businesses that are too small for large public markets. Income comes mainly from interest and fees on its credit portfolio.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 30.8 | — | 16.9 | -40.5% |
| Q2 2025 | 38.4 | — | 26.7 | -7.7% |
| Q3 2025 | 36.4 | — | 25.6 | -17.2% |
| Q4 2025 | 43.9 | — | 32.9 | 9.5% |
| Q1 2026 | 32.6 | 5.9% | 26.3 | 55.7% |
| Q2 2026 | 32.7 | -14.9% | 24.4 | -8.7% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Alkami Technology, Inc. (ALKT), The Pennant Group, Inc. (PNTG), Kailera Therapeutics, Inc. (KLRA), Pacira BioSciences, Inc. (PCRX), Healthcare Services Group, Inc. (HCSG), MillerKnoll, Inc. (MLKN)